The Lancet Diabetes & Endocrinology in conversation with

Professor Roy Taylor joins Lauren Southwell to talk about his Review discussing the causes of type 2 diabetes.Read the full article:https://www.thelancet.com/journals/landia/article/PIIS2213-8587(24)00157-8?dgcid=buzzsprout_icw_podcast_generic_landiaContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Professor Ponnusamy Saravanan, Dr Uma Ram, and Dr Kosgei Wycliffe join Lauren Southwell to discuss STRiDE, a prospective cohort study in India and Kenya, and the multi-ethnic PRiDE cohort in the UK to assess early pregnancy HbA1c as a screening test for gestational diabetes.Read the full article:https://www.thelancet.com/journals/landia/article/PIIS2213-8587(24)00151-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_landiaContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Márta Korbonits talks with The Lancet Diabetes & Endocrinology about mechanisms of ageing: growth hormone, dietary restriction, and metformin.Read the full article:Mechanisms of ageing: growth hormone, dietary restriction, and metforminContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Mirjam Christ-Crain and Cihan Atila talk with The Lancet Diabetes & Endocrinology about central diabetes insipidus from a patient's perspective. Read the full article:Central diabetes insipidus from a patient's perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based surveyContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Niki Karavitaki talks with The Lancet Diabetes & Endocrinology about the risk of a second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma.Read the full article:Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngiomaContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv